| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.042 | 0.8 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.042 | 0.8 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.042 | 0.8 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |